Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Merge Healthcare Incorporated (NASDAQ:MRGE) (?Merge Healthcare?), a leading health IT solutions provider, and etrials Worldwide, Inc. (NASDAQ:ETWC) (?etrials?), a leading...
etrials Worldwide, Inc. (Nasdaq: ETWC), a leading provider of adaptive eClinical solutions , today announced it is launching several of its newest eClinical capabilities...
Merge Healthcare (NASDAQ: MRGE) (?Merge?), a health IT solutions provider, and etrials Worldwide, Inc. (NASDAQ: ETWC) (?etrials?), a provider of clinical trials software and...
Merge Healthcare (NASDAQ:MRGE) (?Merge?), a leading health IT solutions provider, and etrials Worldwide, Inc. (NASDAQ:ETWC) (?etrials?), a leading provider of clinical trials...
etrials Worldwide, Inc. (Nasdaq: ETWC), a leading provider of adaptive eClinical solutions, and Ockham Development Group -- a global contract research and development...
etrials Worldwide, Inc. (Nasdaq: ETWC), a leading provider of adaptive eClinical software and services designed to optimize clinical trial management by turning data into...
Bio-Imaging Technologies, Inc. (NASDAQ: BITI) (d/b/a "BioClinica?) and etrials Worldwide, Inc. (NASDAQ: ETWC) (?etrials?) jointly announce that, in response to an unsolicited...
etrials Worldwide, Inc. (Nasdaq: ETWC), a leading provider of adaptive eClinical software and services designed to optimize clinical trial management by turning data into...
Bio-Imaging Technologies, Inc. (NASDAQ: BITI) (d/b/a "BioClinica?) and etrials Worldwide, Inc. (NASDAQ: ETWC) (?etrials?) jointly announce Bio-Imaging?s intent to acquire...
etrials Worldwide, Inc. (Nasdaq: ETWC), a leading provider of adaptive eClinical software and services designed to optimize clinical trial management by turning data into...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
